These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23157358)

  • 21. Bioinformatics strategies for translating genome-wide expression analyses into clinically useful cancer markers.
    Rhodes DR; Chinnaiyan AM
    Ann N Y Acad Sci; 2004 May; 1020():32-40. PubMed ID: 15208181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer biomarkers: current issues and future directions.
    Jain KK
    Curr Opin Mol Ther; 2007 Dec; 9(6):563-71. PubMed ID: 18041667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers for lung cancer: clinical uses.
    Greenberg AK; Lee MS
    Curr Opin Pulm Med; 2007 Jul; 13(4):249-55. PubMed ID: 17534168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive markers in early research and companion diagnostic developments in oncology.
    Pickl M; Ruge E; Venturi M
    N Biotechnol; 2012 Sep; 29(6):651-5. PubMed ID: 22484859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translation of neurological biomarkers to clinically relevant platforms.
    Hayes RL; Robinson G; Muller U; Wang KK
    Methods Mol Biol; 2009; 566():303-13. PubMed ID: 20058180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges in cancer research and multifaceted approaches for cancer biomarker quest.
    Martinkova J; Gadher SJ; Hajduch M; Kovarova H
    FEBS Lett; 2009 Jun; 583(11):1772-84. PubMed ID: 19327356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The biggest challenges currently facing companion diagnostic advancement.
    Halim AB
    Expert Rev Mol Diagn; 2014 Jan; 14(1):27-35. PubMed ID: 24308333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-platform method for identifying candidate network biomarkers for prostate cancer.
    Jin G; Zhou X; Cui K; Zhang XS; Chen L; Wong ST
    IET Syst Biol; 2009 Nov; 3(6):505-12. PubMed ID: 19947776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Proteomics for biomarker development toward personalized medicine].
    Kondo T
    Rinsho Byori; 2012 Jul; 60(7):644-9. PubMed ID: 22973724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy.
    Cho WC
    Int J Biochem Cell Biol; 2010 Aug; 42(8):1273-81. PubMed ID: 20026422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic biomarkers for cancer assessment: implementation challenges for laboratory practice.
    Pritzker KP; Azad A
    Clin Biochem; 2004 Jul; 37(7):642-6. PubMed ID: 15234245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer: a proteomic disease.
    Li G; Xiao Z; Liu J; Li C; Li F; Chen Z
    Sci China Life Sci; 2011 May; 54(5):403-8. PubMed ID: 21455689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Front-line drug discovery system for cancer].
    Mizukami T
    Gan To Kagaku Ryoho; 2008 Dec; 35(13):2293-300. PubMed ID: 19098393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer epigenomics: beyond genomics.
    Sandoval J; Esteller M
    Curr Opin Genet Dev; 2012 Feb; 22(1):50-5. PubMed ID: 22402447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using biointelligence to search the cancer genome: an epistemological perspective on knowledge recovery strategies to enable precision medical genomics.
    Mousses S; Kiefer J; Von Hoff D; Trent J
    Oncogene; 2008 Dec; 27 Suppl 2():S58-66. PubMed ID: 19956181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practical perspectives of personalized healthcare in oncology.
    Hodgson DR; Wellings R; Harbron C
    N Biotechnol; 2012 Sep; 29(6):656-64. PubMed ID: 22426411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.
    Parkinson DR; Johnson BE; Sledge GW
    Clin Cancer Res; 2012 Feb; 18(3):619-24. PubMed ID: 22298894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of tissue microarrays in prostate cancer biomarker discovery.
    Datta MW; True LD; Nelson PS; Amin MB
    Adv Anat Pathol; 2007 Nov; 14(6):408-18. PubMed ID: 18049130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic microarrays in cancer molecular diagnostics: just biomarker discovery tools or future bedside clinical assays?
    Ross JS
    Expert Rev Mol Diagn; 2005 Nov; 5(6):837-8. PubMed ID: 16255622
    [No Abstract]   [Full Text] [Related]  

  • 40. An exploration into study design for biomarker identification: issues and recommendations.
    Hall JA; Brown R; Paul J
    Cancer Genomics Proteomics; 2007; 4(3):111-9. PubMed ID: 17878515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.